Start a live chat
1-800-870-4800
The half-life of collagen —
how often the body replaces
its own structural protein.
Most proteins in the body turn over in hours or days. Collagen does not. The literature describes collagen half-lives ranging from weeks in some tissues to years in others — and in dense connective tissue, the same collagen molecule may remain in place for the better part of a human lifetime. Slow turnover is one of the most distinctive features of the protein family that builds skin, bone, tendon, and cartilage.
I
Protein turnover, and why collagen is the unusual case —
the slow exception to a fast biology.
Every protein in the body is replaced. The ribosomes that produce a given enzyme do not produce it once and walk away — they produce it again, and again, and again, while the older copies of the protein are simultaneously broken down by the proteasome and lysosomal pathways. This continuous making and unmaking is called protein turnover, and it runs across essentially every protein the body contains. The rate, however, varies enormously. Some signalling proteins are replaced within minutes of being made; the body needs their concentrations to change rapidly in response to circumstance, and slow turnover would make that impossible. Most cellular enzymes turn over in hours to days. Most circulating proteins — the albumin in blood plasma, for example — turn over in weeks. And then there is collagen, which sits at the slow extreme of the distribution.
The reason collagen turns over slowly is structural. The triple-helix architecture assembled by fibroblasts and other connective-tissue cells is, once secreted into the extracellular matrix, locked together by the chemical crosslinks that the next article in this series describes in detail. Those crosslinks make the fibril mechanically strong and they also make it resistant to enzymatic breakdown. A protein that is essentially insoluble in water, packed into bundles, and covalently linked to its neighbours cannot be turned over the way a soluble cytoplasmic enzyme is. The body has evolved a specific set of enzymes — collagenases and other matrix metalloproteinases — to break collagen down when turnover does occur, and the slow tempo of their work is what determines collagen's characteristic half-life across tissues.
What follows from this is that collagen content in any given tissue is not the result of a single act of production. It is the product of a continuous, slow balance between production by fibroblasts and degradation by matrix-metalloproteinase enzymes — a balance the literature describes as matrix homeostasis. Skin, tendon, cartilage, and bone each settle this balance at a different rate, and each ends up with a different characteristic turnover time. The biosynthesis side of this balance was the subject of the earlier article in this series; the breakdown side is the subject of a later article. This piece is about the time scale at which the balance operates.
A signalling protein lasts minutes.
A cellular enzyme lasts hours.
A collagen molecule in dense connective tissue
may last most of a human lifetime.
Turnover by tissue — the four tempos
Different tissues replace their collagen
at substantially different rates.
The literature describes collagen turnover rates that span more than three orders of magnitude across tissues — from weeks in the most active connective compartments to multiple decades in the densest and most mechanically loaded. The figures below summarise the patterns documented in published studies; like all turnover measurements, they are estimates derived from indirect tracer methods rather than exact half-lives in the chemical-kinetic sense.
Tissue 01
Skin
Weeks to months
Dermal collagen is among the most actively turned over collagen pools in the body — the literature describes characteristic replacement times in the range of weeks to months for the more superficial layers, with deeper dermal collagen turning over more slowly. The dermis is mechanically active and metabolically rich, and its fibroblasts maintain a relatively high baseline production rate.
Tissue 02
Tendon · Ligament
Years
Tendons and ligaments turn over their collagen on a timescale of years. The parallel-bundle Type I architecture of these tissues is mechanically suited for tensile load along a single axis, and the slow turnover reflects both the structural cost of replacing such a precisely organised matrix and the relatively low metabolic activity of mature tendon and ligament tissue.
Tissue 03
Cartilage
Decades
Articular cartilage collagen — predominantly Type II — turns over on a timescale measured in decades. The literature documents articular cartilage collagen as among the most stable protein pools in the human body, with half-lives that may approach a human lifetime in healthy adult joint tissue. The combination of low cellularity (chondrocytes are sparse) and avascular matrix architecture is what produces this characteristic slowness.
Tissue 04
Bone matrix
~15 years
The Type I collagen scaffold of bone turns over on a timescale of roughly 10–15 years for the cortical matrix, with trabecular bone collagen turning over somewhat faster. Bone remodelling involves coordinated cycles of osteoclast resorption and osteoblast formation, and the collagen matrix produced during each cycle settles in for the duration of that remodelling interval.
II
The mechanism behind slow turnover —
why the body keeps its collagen for as long as it does.
The molecular reason collagen turns over slowly is the resistance of the crosslinked fibril to enzymatic attack. A native collagen triple helix, by itself in solution, is relatively stable but accessible to general proteases over time. A collagen fibril, however — assembled from hundreds of triple-helix molecules packed in a staggered overlap and covalently crosslinked to its neighbours — is essentially refractory to general proteolysis. The body has evolved a specialised family of enzymes, the matrix metalloproteinases or MMPs, that can cleave the native triple helix at specific sites; these enzymes are the only ones capable of initiating collagen breakdown under physiological conditions, and their activity is tightly regulated by inhibitor proteins called TIMPs. The MMP family and its regulatory layer is the subject of a dedicated article later in this cluster.
The implication is that collagen turnover is not a passive process of natural protein degradation. It is an active, enzyme-mediated, tissue-regulated process — the body chooses when and where to break collagen down, and the rate of that choice determines the half-life observed in any given tissue. Tissues that are mechanically active and frequently remodelled (skin, gut, vasculature) maintain higher MMP activity and faster turnover. Tissues that are mechanically stable and structurally committed (bone, tendon, cartilage) maintain low MMP activity and slow turnover. The mechanical environment of the tissue, the cytokine signals it receives, and the demands of remodelling after injury all modulate this regulation. The fibroblast at the centre of this process responds to those signals by adjusting both its production rate and its release of MMPs into the surrounding matrix.
What this means in practical biological terms is that the collagen present in any tissue at any given moment is, statistically, the survivor of years of selective replacement. The amino acids in a tendon today were assembled into a triple helix some number of years ago — possibly several years for a non-injured tendon in an adult. The amino acids in articular cartilage today may have been there since adolescence. This is the slow tempo of collagen as a structural protein, and it is one of the underlying reasons that dietary input is best understood as a continuous supply rather than an episodic correction. Modern formulations like Codeage's Multi Collagen Protein Powder draw on the same multi-type amino acid profile every day, recognising that the body's own turnover tempo runs on the same continuous basis.
Slow turnover is not a flaw of the body.
It is a feature.
A connective-tissue protein that lasted only hours
would not hold a tendon together at all.
Collagen turnover in numbers
The half-life of collagen across tissues,
at three orders of magnitude.
Weeks
Approximate turnover time for the most actively remodelled collagen pools — the superficial dermis and certain epithelial basement membranes
Skin's most active collagen pools turn over on the order of weeks to a few months, the fastest tempo observed for collagen anywhere in the body. The dermis maintains a population of metabolically active fibroblasts and a relatively high baseline MMP activity, both of which contribute to the comparatively rapid turnover described in dermal-tissue studies.
Years
Characteristic turnover time for tendon and ligament collagen — orders of magnitude slower than typical cellular proteins
Tendon and ligament collagen turn over on a timescale of years, with some studies in the literature reporting effective half-lives of a decade or more for the deepest tendon matrix. The slow tempo is consistent with the parallel-bundle Type I architecture and the relatively low metabolic activity of mature tendon tissue.
Decades
Approximate turnover time for articular cartilage collagen — among the slowest protein turnover the human body maintains
Type II collagen in articular cartilage is documented in the research literature as one of the longest-lived protein pools in the body, with effective half-lives that may approach a human lifetime in healthy adult joint tissue. The combination of sparse chondrocyte populations and avascular matrix architecture produces this characteristic slowness.
III
What slow turnover means
for how to think about dietary substrate supply.
The practical implication of collagen's slow turnover is straightforward. Because the body replaces its connective-tissue collagen continuously across years and decades, the amino acid substrate the body draws on for that replacement is also drawn on continuously — not episodically. The glycine, proline, and hydroxyproline-precursor required by fibroblasts and other collagen-producing cells are needed every day across decades, in the same proportions that the collagen family contains them.
This is, biologically, the framing in which any collagen-rich dietary input is most coherently understood. It is not an intervention timed to a specific outcome window. It is a continuous supply input that runs alongside the body's own continuous turnover process. The amino acids supplied today contribute to the collagen produced over the months and years that follow; the amino acids supplied a year ago contribute to the collagen turning over a year from now. The continuity of supply matches the continuity of demand. Codeage's Multi Collagen Protein Powder, drawing five collagen types from four sources in a hydrolysed peptide format, is built around this framing — daily input matched to the slow continuous tempo of collagen biology rather than to any acute intervention.
As with the rest of structural protein biology, the precise rates of collagen turnover across tissues continue to be refined as research methods evolve, and the figures cited in this article reflect the current state of the literature rather than a closed account. The studies referenced were conducted independently and did not involve any specific Codeage product — what is described here is the underlying biology of collagen turnover, not a claim about the effect of any formulation on it. The next article in this cluster turns from the time-scale of turnover to its mechanical basis: the crosslinks that lock collagen fibrils into the architectural state from which slow turnover proceeds. For the wider context, The Longevity Code situates this dimension of structural protein biology within the four-pillar daily framework of the Codeage system.
Codeage · Structural Integrity · Pillar 02
A multi-collagen architecture,
built around the daily.
Three formulations from the Codeage collagen line — each supplying the five-type, four-source multi-collagen profile in a different format for daily use.
Multi Collagen Protein Powder
Five collagen types — I, II, III, V, X — drawn from four sources: grass-fed bovine, wild-caught marine, chicken cartilage, and eggshell membrane. Unflavoured. Mixes into water, coffee, or smoothies. The flagship of the Codeage collagen architecture.
View Product →Multi Collagen Peptides Powder Platinum
The Platinum line — five collagen types from four sources combined with biotin, keratin, hyaluronic acid, and adjunct vitamins. Hydrolysed peptide format. Designed for those approaching collagen as part of a broader structural-integrity system.
View Product →Multi Collagen Protein Capsules
The same five-type, four-source multi-collagen profile in capsule form. For those who travel, who prefer not to mix a powder, or who use collagen alongside a daily set of foundation formulations.
View Product →Previously in the Multi-Collagen series
From kólla to modern biology — the long history of collagen.
Codeage · The Longevity Code
A system built for
the structural long view.
The Longevity Code is a four-pillar daily system — every formulation mapped to a specific dimension of how the body sustains itself across time. Multi-collagen is the structural protein of Pillar 02.
Explore The Longevity Code →
